Testing effectiveness (Phase 2)Active Not RecruitingNCT03967223
What this trial is testing
Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors
Who this might be right for
Neoplasms
USWM CT, LLC 103